Hojabr Alimi - Pulmatrix Insider

Pulmatrix Inc -- USA Stock  

USD 1.47  0.02  1.38%

Chairman of the Board, CEO, Chief Science Officer

Mr. Hojabr Alimi has served as our Chief Executive Officer Chief Science Officer and Chairman of our Board of Directors since February 4 2013. Mr. Alimi was also appointed Chairman of our board of directors on that same date. From 1999 to February 2013 Mr. Alimi held the position of President and Chief Executive Officer at our former parent company Oculus a public company which he cofounded with his spouse. Mr. Alimi served as Chairman of the Board of Oculus from 1999 until February 2014. Upon completion of our initial public offering Mr. Alimi resigned from Oculus board of directors. Prior to founding Oculus Mr. Alimi was a corporate microbiologist for Arterial Vascular Engineering
Age: 52  Chairman Since 2013      
781-357-2333  http://www.pulmatrix.com
Alimi received a B.A. in biology from Sonoma State University.

Management Efficiency

The company has return on total asset (ROA) of (48.95) % which means that it has lost $48.95 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (154.45) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 3.9 M in liabilities with Debt to Equity (D/E) ratio of 30.4 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Pulmatrix Inc has Current Ratio of 1.14 suggesting that it may have difficulties to pay its financial obligations when they are due.

Similar Executives

Entity Summary

Pulmatrix, Inc., a clinical stage biopharmaceutical company, engages in developing inhaled therapies to address serious pulmonary diseases using its inhaled Small Particles Easily Respirable and Emitted technology. Pulmatrix Inc (PULM) is traded on NASDAQ General Markets in USA. It is located in MASSACHUSETTS, U.S.A and employs 18 people. Pulmatrix is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Portfolio Optimization Now

Portfolio Optimization

Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Hide  View All  NextLaunch Portfolio Optimization
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Pulmatrix Inc to your portfolio

Top Management

Pulmatrix Inc Leadership Team
Terrance McGuire, Director, MBA
Matthew Sherman, Director
Alexander Klibanov, Founder
David Hava, Executive, Ph.D
Akihisa Akao, Director
James Roach, Executive, Ph.D
Michael Higgins, Director, MBA
Steven Gillis, Director
Jean Sung, President
William Duke, CFO, MBA
David Maki, Director
Robert Clarke, CEO, Ph.D
Scott Rocklage, Director, Ph.D
Kurt Graves, Director
Richard Conley, Director, MBA
Mark Iwicki, Chairman, MBA
Amit Munshi, Director, MBA
Gregory French, Director
Hojabr Alimi, Chairman
Prof Edwards, Founder
David JD, Executive

Stock Performance

Pulmatrix Performance Indicators